Search Results - "Ampofo, W.K"

CD4+ T cell counts in initiation of antiretroviral therapy in HIV infected asymptomatic individuals; controversies and inconsistencies by Maina, E.K, Bonney, E.Y, Bukusi, E.A, Sedegah, M, Lartey, M, Ampofo, W.K

“…Highlights • Assesses available data on optimal time to initiate therapy in HIV-infected asymptomatic individuals with respect to CD4+ T cell threshold. •…”
Get full text

Plasma concentrations of transforming growth factor beta 1 in non-progressive HIV-1 infection correlates with markers of disease progression by Maina, Edward K., Abana, C.Z., Bukusi, E.A., Sedegah, M., Lartey, M., Ampofo, W.K.

“…•T-cell phenotypes are not restored after ART/viral suppression in HIV-1 infection.•TGF β 1 and IL-10 may explain lack of CD4+ T-cells recovery in progressive…”
Get full text

Relationship between immunoclinical status and prevalence of viral sexually transmitted diseases among human immunodeficiency virus-1 seropositive patients in Ghana by Brandful, J A, Apeagyei, F A, Ampofo, W K, Adu-Sarkodie, Y, Ansah, J E, Nuvor, V, Aidoo, S, Ishikawa, K, Sata, T, Yamamoto, N, Yamazaki, S

“…In view of the strong association between the acquired immunodeficiency syndrome (AIDS) and sexually transmitted diseases (STDs), we screened 182 human…”
Get more information

Randomized, controlled trial of trivalent oral poliovirus vaccine (Sabin) starting at birth in Ghana by OSEI-KWASI, M, AFARI, E. A, MIMURA, K, OBENG-ANSAH, I, AMPOFO, W. K, NKRUMAH, F. K

“…To evaluate the efficacy of the schedule currently recommended for immunization with trivalent oral poliovirus vaccine (TOPV) (i.e., at birth, 6 weeks, 10…”
Get full text